Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docetaxel (DTX) - Ifosfamide (IFX) As First Line Chemotherapy In Metastatic Breast Cancer

NCT00026078 is registered in ClinicalTrials.gov with Grupo Oncologico Cooperativo del Sur as lead sponsor.

NCT NCT00026078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docetaxel (DTX) - Ifosfamide (IFX) As First Line Chemotherapy In Metastatic Breast Cancer
Lead sponsor
Grupo Oncologico Cooperativo del Sur
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2001
Completion date
Not reported
Enrollment
42 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer